News & Events for Human Drugs
New and updated webpages
Follow us
Events
Meetings, Conferences, and Workshops
Sponsored or co-sponsored by FDA's Center for Drug Evaluation and Research (CDER)
Podcasts
FDA Drug Safety Podcasts
Emerging safety information about drugs in conjunction with the release of Drug Safety Communications
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
Information about current topics in cancer drug development
CDER SBIA Chronicles
Useful information for industry to assist in all aspects of drug marketing and regulation
Features
CDER Conversations
Discussions with key CDER leadership about important regulatory and policy issues
From Our Perspective
An insider's look at changes, initiatives and advances in drug development, review, and approval
Spotlight on CDER Science
CDER Scientists describe scientific advancements aimed at improving drug development
Things to Know About...
Fast facts about CDER's efforts and actions
Recently published Drug-related Guidances
Oct 30
E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers (R1)
Oct 29
Essential Drug Delivery Performance Characteristics for Devices Intended to Deliver Drugs and Biological Products
Oct 20
Regulatory Considerations for Prescription Drug Use-Related Software
Paragraph Header
Contact FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Building 51, Room 1109
Silver Spring, MD 20993
For Latest Updates Follow
@FDAdrugs
Your source for the latest drug information.
Know the moment it happens.